medigraphic.com
ISSN 0188-9796 (Print)

2013, Number 4

<< Back Next >>

Rev Endocrinol Nutr 2013; 21 (4)

Adrenal incidentaloma. Case report and literature review

Rivera-Hernández A, Díaz-Zavala F

Language: Spanish
References: 20
Page: 182-186
PDF size: 211.98 Kb.


ABSTRACT

The prevalence of adrenal incidentaloma by ultrasonography is 0.1% compared to 1.9% by computed tomography. Adrenal incidentaloma produces hormones in 15% of cases. In this report we present the approach to this pathology with a clinical case.


REFERENCES

  1. Linos D: Adrenal incidentaloma (adrenaloma). Hormones. 2003; 2: 12-21.

  2. Brunt LM, Moley JF: Adrenal incidentaloma. World J Surg. 2001; 25: 905-913.

  3. Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis: Adrenal incidentaloma: a diagnostic challenge. Hormones. 2009; 8: 163-184.

  4. Israel GM, Krinsky GA: MR imaging of kidneys and adrenal glands. Radiol Clin N Am. 2003; 41: 145-159.

  5. Barzon E, Sonino N, Fallo F, Palu G, Boscaro M: Prevalence and natural history of adrenal incidentalomas.

  6. Eur J Endocrinol. 2003; 149: 273-285.

  7. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M: Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006; 29: 298-302.

  8. Rossi R, Tauchmanova L, Luchiano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G: Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 2000; 85: 1440-1448.

  9. Ṧtrauch B, Widimskỳ J, Ṧindelka G, Ṧkrha J: Does the treatment of primary hyperaldosteronism influence glucose tolerance? Physiol Res. 2003; 52: 503-506.

  10. Plouin PF, Duclos JM, Soppelsa F, Boubilil G, Chatellier G: Factors associated with perioperative morbidity and mortality in patient with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001; 86: 1480-1486.

  11. Fernández-Real JM, Gonzalbez J, Ricat W: Metabolic abnormalities in patients with adrenal incidentaloma. J Clin Endocrinol Metab. 2001; 86: 950b-951b.

  12. Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I: Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf). 2009; 70: 674-679.

  13. Rockall AG, Babar SA, Aslam SA, Isidori AM, Díaz-Cano S, Monson JP, Grossman B, Reznek RH: CT and MR imaging of the adrenal glands in ACTH–independent Cushing syndrome. Radiographics. 2004; 24: 435-452.

  14. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab. 2000; 85: 637-644.

  15. Wajchenberg BL, Albergaria PM, Medonca BB, Latronico AC, Campos CP, Ferreira AV, Zerbini MC, Liberman B, Gomes GC, Kirsher MA: Adrenocortical carcinoma. Cancer. 2000; 88: 711-736.

  16. McLean K, Lilienfeld H, Caracciolo JT, Hoffe S, Tourtelot JB, Carter B: Management of isolated adrenal lesions in cancer patients. Cancer Control. 2011; 18: 113-126.

  17. Ahmad N, Kosar T, Rawa IA, Qayum A: Giant adrenal myelolipoma: incidentaloma with a rare incidental association. Urology Annals. 2010; 2: 130-133.

  18. Baid SK, Rubino D, Sinai N, Ramsey S, Frank A, Nieman LK: Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endocrinol Metab. 2009; 94:3864.

  19. Findling JW, Raff H: Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin N Am. 2005; 34: 385-402.

  20. Kapoor A, Morris T, Rebello R: Guidelines for management of the incidentally discovered adrenal mass. Can Urol Assoc J. 2011; 5: 241-247.




2020     |     www.medigraphic.com